Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
February 23, 2021 at 04:06 pm EST
Enzon Pharmaceuticals, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was USD 52,000 compared to USD 207,000 a year ago. Operating loss was USD 1.305 million compared to USD 973,000 a year ago. Net loss was USD 1.311 million compared to USD 979,000 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.